Video-Interpreting in an Emergency Trauma Room Setting - a Feasibility Trial

October 1, 2025 updated by: Christina Hafner, Medical University of Vienna

Background: Global migration increases the likelihood of language barriers. In medical situations language barriers have a negative effect on quality of treatment and thus endanger patient safety.

In-hospital settings feasibility of video-translation has been demonstrated, yet there is lack of evidence in emergency trauma rooms. There, the physicians have to deal with time-critical decisions. Aims: This feasibility trial aims to investigate technical feasibility, usability as well as the impact on decision-making (e.g. alteration of treatment strategies). Methods: In this study 50 responsive patients with language barriers will be included. The anesthesiologic emergency physician will start video-translation via a tablet. Feasibility, quality of communication, usability as well as changes in diagnosis and treatment will be gathered and analyzed.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
    • Vienna
      • Vienna, Vienna, Austria, 1090
        • MUVienna

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

In total 50 adult patients with language barriers, who are treated in the emergency trauma room by doctors of the Department of Anaesthesia, Intensive Care Medicine and Pain Medicine will be included in this study. Inclusion and exclusion criteria as noted above will be followed.

Description

Inclusion Criteria:

  • adult patients, at least 18 years old
  • awake, responsive patients
  • language barrier (Albanian, Dari, Romanian, Turkish, Modern Standard Arabic, Arabic, Farsi, Russian, Hungarian, Bosnian-Croatian-Serbian, Kurdish (Kurmanci), Slovakian, Bulgarian, Polish, and Czech)

Exclusion Criteria:

  • unconscious patients
  • cardiac arrest patients
  • delay of treatment due to e-translation
  • refusal of video-translation by the patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technical Feasibility
Time Frame: Directly after use of video-interpreting
Occurance of technical problems will be reported
Directly after use of video-interpreting
Usability of video-interpreting
Time Frame: Directly after use of video-interpreting

The usability will be evaluated afterwards by the anesthesiologic emergency physician using a questionnaire including following items on a 7-point Likert scale (strongly disagree to strongly agree):

  • Video-interpreting was easy to use.
  • I feel comfortable to use video-interpreting during the situation.
  • The amount of time involved to use video-interpreting has been fitting for me.
  • I would use video-interpreting again.
  • Video-interpreting was useful for my healthcare practice in this situation.
Directly after use of video-interpreting
Impact on emergency physician's decisions
Time Frame: Directly after use of video-interpreting
The impact of video-translation will be evaluated regarding alteration of medical history or treatment (yes/no)
Directly after use of video-interpreting

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic parameters
Time Frame: Directly after use of video-interpreting

Following characteristics of the patients will be recorded:

Age, gender, primary diagnosis of the physician
Directly after use of video-interpreting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Vienna

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2023

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

October 25, 2023

First Submitted That Met QC Criteria

September 11, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

October 3, 2025

Last Update Submitted That Met QC Criteria

October 1, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1366/2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication Barriers

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe